| __timestamp | Bausch Health Companies Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 1802274 |
| Thursday, January 1, 2015 | 2682700000 | 2512761 |
| Friday, January 1, 2016 | 2810000000 | 2894488 |
| Sunday, January 1, 2017 | 2582000000 | 8096274 |
| Monday, January 1, 2018 | 2473000000 | 7985229 |
| Tuesday, January 1, 2019 | 2554000000 | 8994597 |
| Wednesday, January 1, 2020 | 2367000000 | 29772000 |
| Friday, January 1, 2021 | 2624000000 | 33907000 |
| Saturday, January 1, 2022 | 2625000000 | 26579000 |
| Sunday, January 1, 2023 | 2917000000 | 49868547 |
Unleashing insights
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Bausch Health Companies Inc. and Verona Pharma plc, two prominent players, showcase contrasting strategies over the past decade. From 2014 to 2023, Bausch Health consistently reported SG&A expenses averaging around $2.57 billion annually, reflecting a stable yet high-cost structure. In contrast, Verona Pharma's expenses, though significantly lower, have shown a dramatic increase, rising from approximately $1.8 million in 2014 to nearly $50 million in 2023. This represents a staggering growth of over 2600%, indicating aggressive expansion or increased operational costs. While Bausch Health's expenses peaked in 2023, Verona's rapid rise suggests a strategic shift. Understanding these trends offers insights into each company's operational focus and financial health, providing valuable lessons in cost management and strategic planning.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Bausch Health Companies Inc.
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared